Delcath Systems, Inc. Common Stock (DCTH) Stock
NASDAQ · DCTH
16.11
Fundamentals
Market cap
$559.00M
Price / Earnings ratio
1060.0x
Price / Sales ratio
5.9x
Price / Book ratio
4.7x
Return on assets
0.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Delcath Systems, Inc. Common Stock
No description available.
SectorHealthcare
IndustryMedical Devices
Employees156
CEOMr. Gerard J. Michel MBA, MS
IPO DateMay 29, 2018
HeadquartersQueensbury, NY
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Gerard J. Michel MBA, MS | CEO & Director | 1963 |
| Dr. Martha S. Rook Ph.D. | Chief Operating Officer | 1970 |
| Dr. Vojislav Vukovic M.D., M.Sc., Ph.D. | Chief Medical Officer | 1967 |
| Ms. Sandra Pennell C.P.A. | Chief Financial Officer | 1979 |
| Mr. David Hoffman J.D. | General Counsel, Corporate Secretary & Chief Compliance Officer | 1970 |
| Dr. Johnny John M.D. | Senior Vice President of Clinical Operations & Medical Affairs | 1964 |
| Mr. Kevin Muir | Chief Commercial Officer | — |
| Dr. Michael Brunner M.D. | Senior Vice President of Interventional Oncology | — |
Fundamentals
Valuation
Market cap$559.00M
Price-to-sales ratio5.91
Price-to-book value4.65
Price-earnings ratio1,060.00
Return on Equity1.00%
Return on Sales0.03%
Return on Assets0.01%
PEG ratio1.60
Earnings Per Share
Earnings Per Share$0.01
Income Statement
Average volume398,729
EBITDA$3.02M
1 year high (52w)$17.42
1 year low (52w)$8.12
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



